Discriminative Accuracy of FEV1: FVC Thresholds for COPD-Related Hospitalization and Mortality

被引:151
|
作者
Bhatt, Surya P. [1 ,2 ]
Balte, Pallavi P. [3 ]
Schwartz, Joseph E. [3 ]
Cassano, Patricia A. [4 ]
Couper, David [5 ]
Jacobs, David R., Jr. [6 ]
Kalhan, Ravi [7 ]
O'Connor, George T. [8 ]
Yende, Sachin [9 ,10 ]
Sanders, Jason L. [11 ]
Umans, Jason G. [12 ]
Dransfield, Mark T. [1 ,2 ]
Chaves, Paulo H. [13 ]
White, Wendy B. [14 ]
Oelsner, Elizabeth C. [3 ,15 ]
机构
[1] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, THT 422,1720 Second Ave S, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, UAB Lung Hlth Ctr, Birmingham, AL USA
[3] Columbia Univ, Med Ctr, Div Gen Med, 630 W 168th St,Presbyterian Hosp Ninth Floor, New York, NY 10032 USA
[4] Weill Cornell Med Coll, Div Nutr Sci, Ithaca, NY USA
[5] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA
[6] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[7] Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA
[8] Boston Univ, Div Pulm Allergy Sleep & Crit Care, Boston, MA 02215 USA
[9] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA
[10] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[11] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA
[12] MedStar Hlth Res Inst, Hyattsville, MD USA
[13] Florida Int Univ, Benjamin Leon Ctr Geriatr Res & Educ, Miami, FL 33199 USA
[14] Tougaloo Coll, Undergrad Training & Educ Ctr, Tougaloo, MS USA
[15] Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
来源
关键词
OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; AMERICAN-COLLEGE; REFERENCE VALUES; TASK-FORCE; MANAGEMENT; DIAGNOSIS; LESS-THAN-0.70; ASSOCIATION; PREVENTION;
D O I
10.1001/jama.2019.7233
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE According to numerous current guidelines, the diagnosis of chronic obstructive pulmonary disease (COPD) requires a ratio of the forced expiratory volume in the first second to the forced vital capacity (FEV1: FVC) of less than 0.70, yet this fixed threshold is based on expert opinion and remains controversial. OBJECTIVE To determine the discriminative accuracy of various FEV1: FVC fixed thresholds for predicting COPD-related hospitalization and mortality. DESIGN, SETTING, AND PARTICIPANTS The National Heart, Lung, and Blood Institute (NHLBI) Pooled Cohorts Study harmonized and pooled data from 4 US general population-based cohorts (Atherosclerosis Risk in Communities Study; Cardiovascular Health Study; Health, Aging, and Body Composition Study; and Multi-Ethnic Study of Atherosclerosis). Participants aged 45 to 102 years were enrolled from 1987 to 2000 and received follow-up longitudinally through 2016. EXPOSURES Presence of airflow obstruction, which was defined by a baseline FEV1: FVC less than a range of fixed thresholds (0.75 to 0.65) or less than the lower limit of normal as defined by Global Lung Initiative reference equations (LLN). MAIN OUTCOMES AND MEASURES The primary outcome was a composite of COPD hospitalization and COPD-related mortality, defined by adjudication or administrative criteria. The optimal fixed FEV1: FVC threshold was defined by the best discrimination for these COPD-related events as indexed using the Harrell C statistic from unadjusted Cox proportional hazards models. Differences in C statistics were compared with respect to less than 0.70 and less than LLN thresholds using a nonparametric approach. RESULTS Among 24 207 adults in the pooled cohort (mean [SD] age at enrollment, 63 [10.5] years; 12 990 [54%] women; 16 794 [69%] non-Hispanic white; 15 181 [63%] ever smokers), complete follow-up was available for 11 077 (77%) at 15 years. During a median follow-up of 15 years, 3925 participants experienced COPD-related events over 340 757 person-years of follow-up (incidence density rate, 11.5 per 1000 person-years), including 3563 COPD-related hospitalizations and 447 COPD-related deaths. With respect to discrimination of COPD-related events, the optimal fixed threshold (0.71; C statistic for optimal fixed threshold, 0.696) was not significantly different from the 0.70 threshold (difference, 0.001 [95% CI, -0.002 to 0.004]) but was more accurate than the LLN threshold (difference, 0.034 [95% CI, 0.028 to 0.041]). The 0.70 threshold provided optimal discrimination in the subgroup analysis of ever smokers and in adjusted models. CONCLUSIONS AND RELEVANCE Defining airflow obstruction as FEV1: FVC less than 0.70 provided discrimination of COPD-related hospitalization and mortality that was not significantly different or was more accurate than other fixed thresholds and the LLN. These results support the use of FEV1: FVC less than 0.70 to identify individuals at risk of clinically significant COPD.
引用
收藏
页码:2438 / 2447
页数:10
相关论文
共 50 条
  • [21] FVC, but not FEV1, is associated with clinical outcomes of asthma-COPD overlap
    Tai Joon An
    Chin Kook Rhee
    Yong Bum Park
    Kwang-Ha Yoo
    Hyoung Kyu Yoon
    Scientific Reports, 12
  • [22] Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort
    Odeyemi, Yewande E.
    Lewis, O'Dene
    Ngwa, Julius
    Dodd, Kristen
    Gillum, Richard F.
    Mehari, Alem
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2019, 111 (01) : 94 - 100
  • [23] FVC, but not FEV1, is associated with clinical outcomes of asthma-COPD overlap
    An, Tai Joon
    Rhee, Chin Kook
    Park, Yong Bum
    Yoo, Kwang-Ha
    Yoon, Hyoung Kyu
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Raised FeNO is associated with lower FEV1 and FEV1/FVC in children with asthma
    Lo, David
    Danvers, Lesley
    Roland, Damian
    Richardson, Matthew
    Yang, Yaling
    Beardsmore, Caroline
    Wilson, Andrew
    Gaillard, Erol
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [25] The Fev1/FVC And COPD Assessment Test Are Predictive Of Classic COPD Phenotypes In Community Practice
    Dandurand, R. J.
    Estepar, R. S. J. Jose
    Bourbeau, J.
    Eidelman, D. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [26] FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease
    Bikov, Andras
    Lange, Peter
    Anderson, Julie A.
    Brook, Robert D.
    Calverley, Peter M. A.
    Celli, Bartolome R.
    Cowans, Nicholas J.
    Crim, Courtney
    Dixon, Ian J.
    Martinez, Fernando J.
    Newby, David E.
    Yates, Julie C.
    Vestbo, Jorgen
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 1135 - 1142
  • [27] Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1
    Geerts, Marcel
    Steenbruggen, Irene
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [28] FEV1:FVC Thresholds for Defining Chronic Obstructive Pulmonary Disease-Reply
    Bhatt, Surya P.
    Schwartz, Joseph E.
    Oelsner, Elizabeth C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (16): : 1611 - 1612
  • [29] IS FEV1/SVC SUPERIOR TO FEV1/FVC IN PREDICTING OBSTRUCTIVE AIRWAY DISEASE?
    Subramanian, Sivasubaiah
    Prasad, Yashneel
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 9 - 9
  • [30] PEF UNDERESTIMATES FEV1 AND FEV1/FVC PARAMETERS IN CHILDREN AND ADULT POPULATION
    SOLINSKI, M.
    DABROWIECKI, P.
    BASZA, M.
    GORSKA, K.
    KORCZYNSK, P., I
    Koltowski, L.
    CHEST, 2022, 161 (06) : 455A - 455A